Postdoctoral associate Sarah Baker, Ph.D., is set to present at the North American Cystic Fibrosis Conference on October 9th and 10th. The title of her presentation is: “Cardiovascular effects of an inhaled B2-agonist are attenuated in cystic fibrosis patients.” Her co-authors include: Stephen R. Karpen, Courtney M. Wheatley, Wayne J. Morgan, Eric M. Snyder, director of the Clinical Exercise Physiology Laboratory.